FDA Inspection 1165285 — Renalytix AI, Inc.
The FDA completed an inspection of Renalytix AI, Inc. on Mar 1, 2022 in Long Island City, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 1, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Long Island City, NY (United States)